0       0

HFSA's 20th Annual Scientific Meeting


Heart Failure Trials – Late Breaking Updates


Description

  • Measurement of spironolactone metabolites in patients with heart failure and preserved ejection fraction enrolled in the TOPCAT trial: New insights into regional variation
  • Q&A
  • Aliskiren Trial to Minimize OutcomeS in Patients with HEart failuRE (ATMOSPHERE) study
  • Q&A
  • Serve-HF Post Hoc Analysis
  • Q&A
  • Adaptive Servo-Ventilation reduces Atrial Fibrillation Burden in Patients with Heart Failure and Sleep Apnea: Results from the CAT-HF Arrhythmia Substudy
  • Q&A
  • Baseline Characteristics and Safety of Empagliflozin (EMPA) in US patients enrolled in the EMPA REG OUTCOME trial
  • Q&A

Moderator(s):

Speaker(s):

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content